Treatment and Prevention of Osteoporosis during COVID-19

Over the last several months, an unique Coronavirus (COVID-19) pandemic has been reported in 219 nations, regions, or territories throughout the world, posing major health risks. The incubation time for viruses ranges from 2 to 14 days. Patients with osteoporosis have been found to be at a higher risk of developing COVID-19-related complications. Osteoporosis is a long-term disease that weakens bones and raises the risk of fracture. To limit the risk of future bone loss, structural integrity deterioration, and fractures, osteoporosis usually need long-term treatment. The identification of persistent osteoporosis issues should not be an unwelcome victim of the COVID-19 epidemic. In COVID-19 infected people, metabolic bone disease can cause difficulties. COVID-19 infected individuals are being treated by orthopaedic doctors who have been reassigned to other facilities. As a result, mandatory training for orthopaedics is required to grasp the signs of this illness. In a hospital setting with limited medical personnel and operating facilities, orthopaedic surgery and trauma surgery are difficult to perform. Clinicians must address the challenges posed by the crisis and explore how to continue to assist patients with chronic conditions in reducing morbidity and death

    Related Conference of Treatment and Prevention of Osteoporosis during COVID-19

    February 24-25, 2025

    34th European Diabetes Congress

    London, UK
    March 10-11, 2025

    4th Global Summit on Physiology and Metabolism of Thyroid

    Singapore City, Singapore
    March 17-18, 2025

    5th European Endocrinology and Diabetes Congress

    Paris, France
    April 10-11, 2025

    5th World Congress on Endocrine and Diabetes

    Dubai, UAE
    April 10-11, 2025

    4th International Summit on Hormonal Disorders

    Dubai, UAE
    May 19-20, 2025

    6th World Summit on Diabetes

    Rome, Italy
    June 04-05, 2025

    4th World Congress on Diabetes and Pediatric Endocrinology

    Edinburgh, Scotland
    July 29-30, 2025

    15th World Congress on Endocrinology and Diabetes

    Aix-en-Provence, France
    September 08-09, 2025

    3rd World congress and Expo on Diabetes

    Frankfurt, Germany
    November 20-21, 2025

    21st World Congress on Endocrinology & Diabetes

    Aix-en-Provence, France

    Treatment and Prevention of Osteoporosis during COVID-19 Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in